BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 11, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	12,238	14,902	-	-	-	-
Enterprise Value	11,976	15,314	-	-	-	-
Last Close Price	138.54	168.70	-	-	-	-
PE Ratio	20.43	33.33	-	-	-	-
Forward PE	-	22.57	-	-	-	-
PS Ratio	1.49	2.55	-	-	-	-
PB Ratio	2.44	3.20	-	-	-	-
P/TBV Ratio	2.44	3.20	-	-	-	-
P/OCF Ratio	17.14	49.71	-	-	-	-
EV/Sales Ratio	1.46	2.62	-	-	-	-
EV/EBITDA Ratio	9.49	16.53	-	-	-	-
EV/EBIT Ratio	12.19	20.85	-	-	-	-
Debt / Equity Ratio	0.33	0.37	0.94	1.32	0.96	0.61
Debt / EBITDA Ratio	1.29	1.86	2.96	8.59	6.45	1.42
Debt / FCF Ratio	4.88	-	4.24	-	-	-
Net Debt / Equity Ratio	-0.05	0.05	0.80	1.11	0.02	-0.26
Net Debt / EBITDA Ratio	-0.21	0.23	2.54	7.26	0.13	-0.61
Net Debt / FCF Ratio	-0.78	-7.19	3.63	-1.02	-0.04	1.03
Asset Turnover	0.89	0.83	0.64	0.36	0.41	0.87
Inventory Turnover	2.35	2.70	2.44	2.16	2.79	3.24
Quick Ratio	0.77	1.07	0.40	0.39	2.47	3.16
Current Ratio	1.71	2.36	1.17	1.13	3.21	4.19
Return on Equity (ROE)	12.71%	12.74%	17.79%	7.85%	18.65%	54.07%
Return on Assets (ROA)	6.66%	6.55%	7.71%	3.33%	4.08%	18.59%
Return on Invested Capital (ROIC)	11.96%	9.94%	11.18%	6.58%	14.48%	84.28%
Return on Capital Employed (ROCE)	14.50%	11.20%	16.00%	6.30%	6.50%	23.80%
Earnings Yield	4.89%	3.00%	-	-	-	-
FCF Yield	2.72%	-0.20%	-	-	-	-
Buyback Yield / Dilution	-28.87%	-27.79%	-	-0.01%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.